Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 4.06 | 4.62 | 4.47 | 8.62 |
Depreciation/ Depletion | 9.13 | 9.27 | 7.45 | 5.59 |
Amortization | 1.58 | - | - | - |
Non- Cash Items | 7.78 | 7.65 | 3.99 | -2.94 |
Changesin Working Capital | -5.61 | -14.17 | 0.73 | 2.90 |
Cashfrom Operating Activities | 15.52 | 7.37 | 16.64 | 14.18 |
Capital Expenditures | -7.95 | -4.00 | -51.11 | -22.82 |
Cashfrom Investing Activities | -7.95 | -4.00 | -51.11 | -22.82 |
Financing Cash Flow Items | -6.25 | - | -2.81 | - |
Issuance( Retirement)of Stock Net | 0.00 | 3.28 | 2.40 | 3.82 |
Issuance( Retirement)of Debt Net | -1.30 | -6.99 | 35.43 | 4.96 |
Cashfrom Financing Activities | -7.56 | -3.71 | 35.02 | 8.78 |
Net Changein Cash | 0.01 | -0.34 | 0.55 | 0.14 |
Cash Interest Paid | 7.78 | 7.65 | 3.99 | - |
Cash Taxes Paid | 1.68 | 1.03 | 2.27 | - |
Vivo Bio Tech Dividend Vivo Bio Tech Bonus Vivo Bio Tech News Vivo Bio Tech AGM Vivo Bio Tech Rights Vivo Bio Tech Splits Vivo Bio Tech Board Meetings Vivo Bio Tech Key Metrics Vivo Bio Tech Shareholdings Vivo Bio Tech Profit Loss Vivo Bio Tech Balance Sheet Vivo Bio Tech Q1 Results Vivo Bio Tech Q2 Results Vivo Bio Tech Q3 Results Vivo Bio Tech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks